Skip to content

RIGHTEST iFree2

by Bionime Corporation 2 variants

Ref R0C073Model HR510

Active European Union

CE MDR

Valid until

Not listed

EUDAMED holds no validity date

FDA recalls

Not applicable

No FDA record for this device

Documents

None linked in EUDAMED

A group certificate may exist

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source EUDAMED, synced 23 Oct 2026. What this means

Regulatory status

as of registry sync 23 Oct 2026

RegionAuthorizationNumberDateStatus
European UnionCE/MDR Number471094933CGM000069U Basic UDI-DI 04719897813001UDI-DIDate23 Jul 2026RegisteredStatusActive

Certificates

0 certificates · EUDAMED

EUDAMED lists no certificate for this device's Basic UDI-DI.

A certificate issued for a device group may exist without being linked here.

Coverage

1 jurisdiction

SwedenFinlandLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaAustriaHungaryRomaniaSloveniaBulgariaPortugalSpainItalyCroatiaGreeceMaltaCyprus
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

European Union — CE/MDR Active

Specification

EUDAMED

Device Name
RIGHTEST iFree2 Continuous Glucose Monitoring System Receiver
Model / Reference
HR510, R0C073
Primary DI / UDI-DI
04719897813001
Basic UDI-DI
471094933CGM000069U
EMDN Code
Z1204011599 Blood sugar monitoring systems - other
Device Class
Class IIb
EU market of registration
Netherlands

Manufacturer details

EUDAMED SRN
TW-MF-000008450
Authorised representative
Emergo Europe B.V. NL-AR-000000116

Other devices from Bionime Corporation

See all devices from Bionime Corporation →

Properties

  • Measuring Function

Other properties (12)

  • Sterile: No
  • Implantable: No
  • Reusable: No
  • Contains Latex: No
  • Reprocessed: No
  • CMR Substance: No
  • Human-derived: No
  • Human Tissues: No
  • Animal Tissues: No
  • Endocrine Disruptor: No
  • Administering Medicine: No
  • Incorporates Medicinal Product: No